Biotech Investors & VC Firms in North America
286 firms in this list, with a median first check of $500K. 83 of them lead rounds. Generated from verified public data and updated continuously.
Golden Venture Partners
TorontoSeed
Vamare Investments Group
Athens
Stake Capital
Pre-Seed–Series A
1 person
BDC Life Sciences Venture Fund
MontrealPre-Seed–Growth
2 people
Mankind Pharma
New DelhiSeries A
2 people
Qiming Venture Partners USA
CambridgeSeed–Series A
2 people
The Broad Foundations
Los Angeles
2 people
ExtraVallis
Coral GablesPre-Seed–Series A
1 person
Kinled Holding
Hong KongSeed–Series A
1 person
WERU Investment Co. Ltd.
TokyoPre-Seed–Growth
1 person
Aju IB Invesment Corporation
SeoulSeed–Late Stage
1 person
Alphaket Capital
ArlingtonPre-Seed–Seed$250K
1 person
Salt Mines Advisors
Seed–Series A
1 person
Strategic Innovation Fund
OttawaSeries A
Egora Holding
MartinsriedPre-Seed–Late Stage$5.4M
HaloHealth
TorontoPre-Seed–Series A
Worthwhile Industries Campuses
TorontoLate Stage
Chemelot Ventures
Seed–Late Stage
D3 Jubilee
SeoulSeed–Late Stage
Ela Capital
TorontoPre-Seed–Growth
IKJ Capital
Palo AltoPre-Seed–Series A
fundamenta Life Science
ErkrathSeed–Series A
3 people
Related lists
Crypto & Web3 Investors & VC Firms (4673)Investors & VC Firms in United States (4534)Investors & VC Firms in Global (3593)SaaS Investors & VC Firms (3531)AI & Machine Learning Investors & VC Firms (3411)Fintech Investors & VC Firms (3409)Healthtech Investors & VC Firms (3095)Enterprise Software Investors & VC Firms (2998)Investors & VC Firms in Europe (2640)Consumer Investors & VC Firms (2310)
Data sourced from public filings and firms' own websites — see our methodology.



